About the Cervical Cancer Session
In the realm of cancer research, cervical cancer holds a significant place due to its preventable nature and the potential for early detection. With advancements in screening techniques like Pap smears and HPV testing, there's been a notable decline in cervical cancer cases in many parts of the world. Moreover, the development of HPV vaccines has emerged as a groundbreaking preventive measure against the strains of human papillomavirus responsible for the majority of cervical cancer cases. Cutting-edge research continues to explore novel treatment modalities, including targeted therapies and immunotherapies, offering hope for improved outcomes and quality of life for patients. By integrating innovative approaches to prevention, screening, and treatment, the fight against cervical cancer strides forward, promising a future where this disease is not just treatable, but preventable.
Topics Covered in Cervical Cancer
HPV Vaccination
HPV Primary Screening
High-Grade Lesions
Radical Hysterectomy
Chemoradiation
Checkpoint Immunotherapy
Related Scientific Sessions at CIOC 2027
Why Attend the Cervical Cancer Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Cervical Cancer work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Cervical Cancer research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Cervical Cancer track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Cervical Cancer Conference 2027 — FAQs
What is the Cervical Cancer track at CIOC 2027?
The Cervical Cancer track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Cervical Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Cervical Cancer sessions?
Cancer researchers and clinicians, educators and students with an interest in Cervical Cancer are all welcome — whether presenting or attending.
Can I present my research in the Cervical Cancer track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Cervical Cancer sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Cervical Cancer track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.